Kenneth H. Eckels - Concepedia

Author

Kenneth H. Eckels

Walter Reed Army Institute of Research ORCID

Also Known As

James Wassenberg, K ECKELS, K Eckels, K H Eckels, K. H. ECKELS, K. H. Eckels, K.H. Eckels, KENNETH H. ECKELS, Kenneth Eckels, Kenneth H Eckels

112

Publications

Citations

H-Index

Concepts

All Affiliations

Walter Reed Army Institute of Research University of Maryland, Baltimore GlaxoSmithKline (United States)Beth Israel Deaconess Medical Center Armed Forces Research Institute of Medical Science

About

Kenneth H. Eckels is an author at Walter Reed Army Institute of Research specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	58	5.2K
2	Allergy	3	3	289
3	Cell Biology	2	2	180
4	Public Health	1	1	37
5	Biology	1	1	52

Kenneth H. Eckels

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Vaccine protection against Zika virus from Brazil Rafael A. Larocca, Peter Abbink, Jean Pierre Schatzmann Peron, Nature VaccinationVaccine SafetyVaccine DevelopmentVirologyMedicine	2016	514
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys Peter Abbink, Rafael A. Larocca, Rafael A. De La Barrera, Science VaccinationVaccine SafetyProtective EfficacyVaccine DevelopmentPlasmid Dna Vaccine	2016	500
Rapid development of a DNA vaccine for Zika virus Kimberly A. Dowd, Sung‐Youl Ko, Kaitlyn M. Morabito, Science	2016	400
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials Kayvon Modjarrad, Leyi Lin, Sarah L. George, The Lancet VaccinationVaccine SafetyVaccinologyVaccine TrialPlacebo-controlled Clinical Trials	2017	193
PHASE I TRIAL OF 16 FORMULATIONS OF A TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE Robert Edelman, Steven S. Wasserman, Sacared A Bodison, American Journal of Tropical Medicine and Hygiene VaccinationFormulations 1-15Vaccine DevelopmentNeurovirologyVaccine Target	2003	169
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model J. Robert Putnak, Beth-Ann Coller, Gérald Voss, Vaccine VaccinationRecombinant SubunitVaccine DevelopmentVaccine TargetImmunology	2005	168
Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus Monkeys Robert Putnak, Dave Barvir, Jeanne Burrous, The Journal of Infectious Diseases VaccinationVaccine DevelopmentRhesus MonkeysVaccine TargetImmunology	1996	166
Monoclonal Antibodies against Dengue 2 Virus E-Glycoprotein Protect Mice against Lethal Dengue Infection Bennett Kaufman, P L Summers, D R Dubois, American Journal of Tropical Medicine and Hygiene Lethal Dengue InfectionMedicineHumoral ResponseViral PathogenesisImmunology	1987	154
Production and Evaluation of a Formalin-Killed Chikungunya Vaccine V. R. Harrison, Kenneth H. Eckels, P. J. Bartelloni, The Journal of Immunology VaccinationFormalin-killed Chikungunya VaccineVaccine DevelopmentFormalin-inactivated Chikungunya VaccineImmunogenic Characteristics	1971	146
Monoclonal Antibodies for Dengue Virus prM Glycoprotein Protect Mice against Lethal Dengue Infection Bennett Kaufman, P L Summers, D R Dubois, American Journal of Tropical Medicine and Hygiene VaccinationLethal Dengue InfectionAllergyAutoimmune DiseasePrm Mabs	1989	144

Page 1